{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:40:09Z","timestamp":1749116409186,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10482-025-02096-7","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T05:42:45Z","timestamp":1747978965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering the burden of tuberculosis in Algeria: a retrospective analysis from 2019 to 2024"],"prefix":"10.1007","volume":"118","author":[{"given":"Amina","family":"Zergui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nacim","family":"Bouziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawtar","family":"Fidjel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choubaila","family":"Leksir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamina","family":"Merzouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Hanane","family":"Chentouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Djaballi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebrouk","family":"Kihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2096_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187967","author":"R Al-Rifai","year":"2017","unstructured":"Al-Rifai R, Pearson F, Critchley J, Abu-Raddad L (2017) Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0187967","journal-title":"PLoS ONE"},{"key":"2096_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0970-2113.95320","volume":"29","author":"G Azhar","year":"2012","unstructured":"Azhar G (2012) DOTS for TB relapse in India: a systematic review. Lung India off Organ Indian Chest Soc 29:147\u2013153. https:\/\/doi.org\/10.4103\/0970-2113.95320","journal-title":"Lung India off Organ Indian Chest Soc"},{"key":"2096_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, L\u00f6nnroth K, Ottmani SE, Goonesekera SD, Murray MB (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9:81. https:\/\/doi.org\/10.1186\/1741-7015-9-81","journal-title":"BMC Med"},{"issue":"9","key":"2096_CR4","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1590\/1806-9282.66.9.1196","volume":"66","author":"A Brito","year":"2020","unstructured":"Brito A, De Magalh\u00e3es W, Paiva J, Leal T, Da Silva L, Santos L, Santana G, Fernandes T, Souza C (2020) Tuberculosis in Northeastern Brasil (2001\u20132016): trend, clinical profile, and prevalence of risk factors and associated comorbidities. Rev Assoc Med Bras 66(9):1196\u20131202. https:\/\/doi.org\/10.1590\/1806-9282.66.9.1196","journal-title":"Rev Assoc Med Bras"},{"issue":"9","key":"2096_CR5","doi-asserted-by":"publisher","first-page":"e3409","DOI":"10.1093\/cid\/ciaa1446","volume":"73","author":"V Chidambaram","year":"2021","unstructured":"Chidambaram V, Gupte A, Wang JY, Golub JE, Karakousis PC (2021) The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clin Infect Dis off Publ Infect Dis Soc Am 73(9):e3409\u2013e3418. https:\/\/doi.org\/10.1093\/cid\/ciaa1446","journal-title":"Clin Infect Dis off Publ Infect Dis Soc Am"},{"issue":"12","key":"2096_CR6","doi-asserted-by":"publisher","first-page":"e1329","DOI":"10.1016\/S2214-109X(18)30401-7","volume":"6","author":"PJ Dodd","year":"2018","unstructured":"Dodd PJ, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA (2018) Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study. Lancet Glob Health 6(12):e1329\u2013e1338. https:\/\/doi.org\/10.1016\/S2214-109X(18)30401-7","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2096_CR7","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(22)00875-1","volume":"23","author":"J Dom\u00ednguez","year":"2023","unstructured":"Dom\u00ednguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gr\u00f6schel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C, TBnet and RESIST-TB networks (2023) Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement. Lancet Infect Dis 23(4):e122\u2013e137. https:\/\/doi.org\/10.1016\/S1473-3099(22)00875-1","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"2096_CR8","doi-asserted-by":"publisher","first-page":"CD016013","DOI":"10.1002\/14651858.CD016013.pub2","volume":"8","author":"JV Franco","year":"2024","unstructured":"Franco JV, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Pe\u00f1a Silva L, Boeckmann M, Schlesinger S, Damen JA, Richter B, Baddeley A, Bastard M, Carlqvist A, Garcia-Casal MN, Hemmingsen B, Mavhunga F, Manne-Goehler J, Viney K (2024) Diabetes as a risk factor for tuberculosis disease. Cochrane Database Syst Rev 8(8):CD016013. https:\/\/doi.org\/10.1002\/14651858.CD016013.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2096_CR9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s10461-018-02386-4","volume":"23","author":"YA Gelaw","year":"2019","unstructured":"Gelaw YA, Williams G, Soares Magalh\u00e3es RJ, Gilks CF, Assefa Y (2019) HIV prevalence among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis. AIDS Behav 23(6):1561\u20131575. https:\/\/doi.org\/10.1007\/s10461-018-02386-4","journal-title":"AIDS Behav"},{"issue":"4","key":"2096_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/diagnostics8040078","volume":"8","author":"AD Harries","year":"2018","unstructured":"Harries AD, Kumar AMV (2018) Challenges and progress with diagnosing pulmonary tuberculosis in low- and middle-income countries. Diagnostics 8(4):78. https:\/\/doi.org\/10.3390\/diagnostics8040078","journal-title":"Diagnostics"},{"key":"2096_CR110","doi-asserted-by":"publisher","first-page":"1115295","DOI":"10.3389\/fmicb.2023.1115295","volume":"14","author":"Y He","year":"2023","unstructured":"He Y, Wang Y, Liu L, Li W (2023) The role of gut microbiota in tuberculosis infection and treatment. Front Microbiol  14:1115295. https:\/\/doi.org\/10.3389\/fmicb.2023.1115295","journal-title":"Frontiers in Microbiology"},{"issue":"9","key":"2096_CR11","doi-asserted-by":"publisher","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","volume":"13","author":"KC Horton","year":"2016","unstructured":"Horton KC, MacPherson P, Houben RM, White RG, Corbett EL (2016) Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med 13(9):e1002119. https:\/\/doi.org\/10.1371\/journal.pmed.1002119","journal-title":"PLoS Med"},{"issue":"1","key":"2096_CR12","doi-asserted-by":"publisher","first-page":"e0314693","DOI":"10.1371\/journal.pone.0314693","volume":"20","author":"SS Jama","year":"2025","unstructured":"Jama SS, Abdi MM (2025) Tuberculosis treatment outcomes and associated factors among patients treated at Bosaso TB Hospital, Bosaso, Somalia: a five-year retrospective study. PLoS ONE 20(1):e0314693. https:\/\/doi.org\/10.1371\/journal.pone.0314693","journal-title":"PLoS ONE"},{"key":"2096_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-060906","author":"A Jarde","year":"2022","unstructured":"Jarde A, Romano E, Afaq S, Elsony A, Lin Y, Huque R, Elsey H, Siddiqi K, Stubbs B, Siddiqi N (2022) Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2022-060906","journal-title":"BMJ Open"},{"key":"2096_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003343.pub4","author":"J Karumbi","year":"2015","unstructured":"Karumbi J, Garner P (2015) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003343.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2096_CR15","doi-asserted-by":"publisher","first-page":"CD012768","DOI":"10.1002\/14651858.CD012768.pub3","volume":"1","author":"M Kohli","year":"2021","unstructured":"Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR (2021) Xpert MTB\/RIF Ultra and Xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1(1):CD012768. https:\/\/doi.org\/10.1002\/14651858.CD012768.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2096_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fmed.2017.00171","volume":"4","author":"A Kolloli","year":"2017","unstructured":"Kolloli A, Subbian S (2017) Host-directed therapeutic strategies for tuberculosis. Front Med 4:171. https:\/\/doi.org\/10.3389\/fmed.2017.00171","journal-title":"Front Med"},{"issue":"2","key":"2096_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24(2):351\u2013376. https:\/\/doi.org\/10.1128\/CMR.00042-10","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"2096_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.69605\/ijlbpr_13.6.2024.65","volume":"13","author":"A Lall","year":"2024","unstructured":"Lall A, Cladius S, Mohanty S, Mohanty LK (2024) Comorbidity and tuberculosis: a study of prevalence and impact on disease progression. Int J Leadersh Bus Pract Res 13(6):65\u201378. https:\/\/doi.org\/10.69605\/ijlbpr_13.6.2024.65","journal-title":"Int J Leadersh Bus Pract Res"},{"issue":"2","key":"2096_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","volume":"149","author":"W Lew","year":"2008","unstructured":"Lew W, Pai M, Oxlade O, Martin D, Menzies D (2008) Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 149(2):123\u2013134. https:\/\/doi.org\/10.7326\/0003-4819-149-2-200807150-00008","journal-title":"Ann Intern Med"},{"key":"2096_CR20","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1038\/s41598-024-58080-0","volume":"14","author":"LW Limenh","year":"2024","unstructured":"Limenh LW, Kasahun AE, Sendekie AK, Seid AM, Mitku ML, Fenta ET, Melese M, Workye M, Simegn W, Ayenew W (2024) Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study. Sci Rep 14:7695. https:\/\/doi.org\/10.1038\/s41598-024-58080-0","journal-title":"Sci Rep"},{"issue":"1","key":"2096_CR21","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1371\/journal.pmed.0040020\/","volume":"4","author":"HH Lin","year":"2007","unstructured":"Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4(1):e20. https:\/\/doi.org\/10.1371\/journal.pmed.0040020\/","journal-title":"PLoS Med"},{"issue":"2","key":"2096_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4068\/cmj.2015.51.2.86","volume":"51","author":"V Mahishale","year":"2015","unstructured":"Mahishale V, Patil B, Lolly M, Eti A, Khan S (2015) Prevalence of smoking and its impact on treatment outcomes in newly diagnosed pulmonary tuberculosis patients: a hospital-based prospective study. Chonnam Med J 51(2):86\u201390. https:\/\/doi.org\/10.4068\/cmj.2015.51.2.86","journal-title":"Chonnam Med J"},{"key":"2096_CR23","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-930149\/v1","author":"P Migambi","year":"2021","unstructured":"Migambi P, Dushime A, Karame P et al (2021) Assessment of factors associated with tobacco smoking among patients with pulmonary TB attending health facilities in Rwanda: a case control study. PREPRINT (Version 1). Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-930149\/v1","journal-title":"Res Square"},{"issue":"1","key":"2096_CR24","doi-asserted-by":"publisher","first-page":"e0280678","DOI":"10.1371\/journal.pone.0280678","volume":"18","author":"D Moon","year":"2023","unstructured":"Moon D, Jeong D, Kang YA, Choi H (2023) Gender differences in tuberculosis patients with comorbidity: a cross-sectional study using national surveillance data and national health insurance claims data in South Korea. PLoS ONE 18(1):e0280678. https:\/\/doi.org\/10.1371\/journal.pone.0280678","journal-title":"PLoS ONE"},{"key":"2096_CR25","unstructured":"Nardell EA (2022) Tuberculosis (TB). MSD manual professional version. Retrieved March 16, 2025, from https:\/\/www.msdmanuals.com\/professional\/infectious-diseases\/mycobacteria\/tuberculosis-tb"},{"issue":"12","key":"2096_CR26","doi-asserted-by":"publisher","first-page":"e1000199","DOI":"10.1371\/journal.pmed.1000199","volume":"6","author":"O Neyrolles","year":"2009","unstructured":"Neyrolles O, Quintana-Murci L (2009) Sexual inequality in tuberculosis. PLoS Med 6(12):e1000199. https:\/\/doi.org\/10.1371\/journal.pmed.1000199","journal-title":"PLoS Med"},{"issue":"4","key":"2096_CR27","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S2214-109X(18)30487-X","volume":"7","author":"J Noubiap","year":"2019","unstructured":"Noubiap J, Nansseu J, Nyaga U, Nkeck J, Endomba F, Kaze A, Agbor V, Bigna J (2019) Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2\u00b73 million patients with tuberculosis. Lancet Glob Health 7(4):e448\u2013e460. https:\/\/doi.org\/10.1016\/S2214-109X(18)30487-X","journal-title":"Lancet Glob Health"},{"key":"2096_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1253615","author":"A Nowi\u0144ski","year":"2023","unstructured":"Nowi\u0144ski A, Weso\u0142owski S, Korzeniewska-Kose\u0142a M (2023) The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2023.1253615","journal-title":"Front Public Health"},{"key":"2096_CR29","doi-asserted-by":"publisher","first-page":"997025","DOI":"10.3389\/fpubh.2022.997025","volume":"10","author":"V Peer","year":"2023","unstructured":"Peer V, Schwartz N, Green MS (2023) Gender differences in tuberculosis incidence rates-a pooled analysis of data from seven high-income countries by age group and time period. Front Public Health 10:997025. https:\/\/doi.org\/10.3389\/fpubh.2022.997025","journal-title":"Front Public Health"},{"issue":"6","key":"2096_CR129","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/cpt.2261","volume":"110","author":"CA Peloquin","year":"2021","unstructured":"Peloquin CA, Davies G (2021) Drug-Drug Interactions in Tuberculosis Therapy: The Role of Pharmacogenetics.\nClin Pharmacol Ther  110(6):1496\u20131508. https:\/\/doi.org\/10.1002\/cpt.2261","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"2096_CR30","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1038\/s41598-018-23344-z","volume":"8","author":"JP Samuels","year":"2018","unstructured":"Samuels JP, Sood A, Campbell JR, Ahmad Khan F, Johnston JC (2018) Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis. Sci Rep 8(1):4980. https:\/\/doi.org\/10.1038\/s41598-018-23344-z","journal-title":"Sci Rep"},{"issue":"4","key":"2096_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4103\/ijmr.IJMR_1950_16","volume":"145","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, Sarin R, Paramasivan CN, Kumar P, Nischal N, Khatiwada S, Garner P, Tharyan P (2017) Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res 145(4):448\u2013463. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1950_16","journal-title":"Indian J Med Res"},{"issue":"7","key":"2096_CR132","doi-asserted-by":"publisher","first-page":"e0218058","DOI":"10.1371\/journal.pone.0218058","volume":"14","author":"A Silva-Pinto","year":"2019","unstructured":"Silva-Pinto A, Lemos A, Dias S, Figueiredo AC, Duarte R (2019) Integrating TB and non-communicable diseases services: Pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola. PLoS ONE 14(7):e0218058. https:\/\/doi.org\/10.1371\/journal.pone.0218058","journal-title":"PLoS ONE"},{"issue":"1","key":"2096_CR32","first-page":"74","volume":"10","author":"R Singla","year":"2006","unstructured":"Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis off J Int Union against Tuberc Lung Dis 10(1):74\u201379","journal-title":"Int J Tuberc Lung Dis off J Int Union against Tuberc Lung Dis"},{"issue":"10","key":"2096_CR33","first-page":"1049","volume":"11","author":"K Slama","year":"2007","unstructured":"Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis off J Int Union against Tuberc Lung Dis 11(10):1049\u20131061","journal-title":"Int J Tuberc Lung Dis off J Int Union against Tuberc Lung Dis"},{"issue":"6","key":"2096_CR34","doi-asserted-by":"publisher","first-page":"e044349","DOI":"10.1136\/bmjopen-2020-044349","volume":"11","author":"NN Tao","year":"2021","unstructured":"Tao NN, Li YF, Song WM, Liu JY, Zhang QY, Xu TT, Li SJ, An QQ, Liu SQ, Li HC (2021) Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004\u20132019. BMJ Open 11(6):e044349. https:\/\/doi.org\/10.1136\/bmjopen-2020-044349","journal-title":"BMJ Open"},{"issue":"11","key":"2096_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.7196\/SAMJ.7484","volume":"103","author":"RN van Zyl-Smit","year":"2013","unstructured":"van Zyl-Smit RN, Allwood B, Stickells D, Symons G, Abdool-Gaffar S, Murphy K, Lalloo U, Vanker A, Dheda K, Richards GA (2013) South African tobacco smoking cessation clinical practice guideline. SAMJ S Afr Med J 103(11):869\u2013876","journal-title":"SAMJ S Afr Med J"},{"key":"2096_CR36","doi-asserted-by":"publisher","first-page":"CD003343","DOI":"10.1002\/14651858.cd003343.pub3","volume":"4","author":"J Volmink","year":"2007","unstructured":"Volmink J, Garner P (2007) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 4:CD003343. https:\/\/doi.org\/10.1002\/14651858.cd003343.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2096_CR37","doi-asserted-by":"publisher","first-page":"e0175925","DOI":"10.1371\/journal.pone.0175925","volume":"12","author":"MH Workneh","year":"2017","unstructured":"Workneh MH, Bjune GA, Yimer SA (2017) Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS ONE 12(4):e0175925. https:\/\/doi.org\/10.1371\/journal.pone.0175925","journal-title":"PLoS ONE"},{"key":"2096_CR38","volume-title":"Global tuberculosis report 2023","author":"World Health Organization (WHO)","year":"2023","unstructured":"World Health Organization (WHO) (2023) Global tuberculosis report 2023. WHO Press, Geneva"},{"issue":"1","key":"2096_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12941-017-0239-4","volume":"16","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu J, Liao S, Sun Z (2017) Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. Ann Clin Microbiol Antimicrob 16(1):67. https:\/\/doi.org\/10.1186\/s12941-017-0239-4","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"2096_CR40","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.rmr.2010.10.040","volume":"28","author":"J-P Zellweger","year":"2011","unstructured":"Zellweger J-P (2011) La tuberculose multir\u00e9sistante\u202f: extension, menace et solutions. Rev Mal Respir 28(8):1025\u20131033. https:\/\/doi.org\/10.1016\/j.rmr.2010.10.040","journal-title":"Rev Mal Respir"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-025-02096-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:05:55Z","timestamp":1749114355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-025-02096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s10482-025-02096-7","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"type":"print","value":"0003-6072"},{"type":"electronic","value":"1572-9699"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve direct patient contact, so no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"80"}}